SEC Filing Summary: ADVENTRX Pharmaceuticals, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by ADVENTRX Pharmaceuticals, Inc. on June 2, 2009, regarding events occurring on June 1, 2009. The Company, incorporated in Delaware, operates under the ticker symbol "ANX" on the NYSE Amex LLC. The filing addresses a formal notice of non-compliance with the Exchange's continued listing standards.
Key Financial Metrics and Status
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it references the Company's Form 10-Q for the period ended March 31, 2009, to establish the basis for non-compliance:
- Stockholders' Equity: Reported as less than $4,000,000 (violating Section 1003(a)(ii)) and less than $6,000,000 (violating Section 1003(a)(iii)).
- Profitability: The Company reported losses from continuing operations and net losses in three of its four most recent fiscal years, as well as losses in its five most recent fiscal years.
- Liquidity and Debt: Specific liquidity ratios or debt obligations are not detailed in this document.
Material Changes and Listing Status
The primary material change is the Company's failure to satisfy the NYSE Amex LLC's continued listing standards. Consequently:
- The Company's stock will be subject to a trading symbol extension ".BC" to denote non-compliance.
- The Company must submit a plan to regain compliance by July 1, 2009.
- The target date to regain full compliance is December 1, 2010.
Outlook, Risks, and Management Commentary
Management has verbally informed Exchange staff of its intent to submit a compliance plan by the July 1, 2009 deadline. The Company expects that if a reasonable demonstration of the ability to regain compliance is made, the plan will be accepted, allowing the stock to remain listed during the plan period subject to periodic reviews.
Risks and Contingencies:
- If the Company fails to submit an acceptable plan, or if it fails to make progress consistent with the plan, the Exchange expects to initiate delisting proceedings.
- Delisting proceedings are expected to commence if non-compliance persists past November 29, 2010.
Key Facts for Investor Verification
- Verify the specific stockholders' equity and net loss figures in the Form 10-Q for the period ended March 31, 2009.
- Monitor the submission of the compliance plan by the July 1, 2009 deadline.
- Watch for the application of the ".BC" trading symbol extension on the Company's stock.
- Assess the Company's ability to generate positive equity or profitability by December 1, 2010, to avoid delisting.